| Year |
Citation |
Score |
| 2023 |
Weber MC, Izzo LT, Oliver TG. Epigenetic Regulators Open the Door to SCLC Plasticity. Cancer Research. 83: 3495-3497. PMID 37756567 DOI: 10.1158/0008-5472.CAN-23-2922 |
0.364 |
|
| 2023 |
Pearsall SM, Williamson SC, Humphrey S, Hughes E, Morgan D, García Marqués FJ, Awanis G, Carroll R, Burks L, Shue YT, Bermudez A, Frese KK, Galvin M, Carter M, Priest L, ... ... Oliver TG, et al. Lineage plasticity in SCLC generates non-neuroendocrine cells primed for vasculogenic mimicry. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 37455012 DOI: 10.1016/j.jtho.2023.07.012 |
0.451 |
|
| 2022 |
Chen H, Gesumaria L, Park YK, Oliver TG, Singer DS, Ge K, Schrump DS. BET Inhibitors Target the SCLC-N subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation. Molecular Cancer Research : McR. PMID 36378541 DOI: 10.1158/1541-7786.MCR-22-0594 |
0.359 |
|
| 2022 |
Groves SM, Ildefonso GV, McAtee CO, Ozawa PMM, Ireland AS, Stauffer PE, Wasdin PT, Huang X, Qiao Y, Lim JS, Bader J, Liu Q, Simmons AJ, Lau KS, Iams WT, ... ... Oliver TG, et al. Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer. Cell Systems. PMID 35981544 DOI: 10.1016/j.cels.2022.07.006 |
0.307 |
|
| 2022 |
Kelenis DP, Rodarte KE, Kollipara RK, Pozo K, Pal Choudhuri S, Spainhower KB, Wait SJ, Stastny V, Oliver TG, Johnson JE. Inhibition of karyopherin β1-mediated nuclear import disrupts oncogenic lineage- defining transcription factor activity in small cell lung cancer. Cancer Research. PMID 35748745 DOI: 10.1158/0008-5472.CAN-21-3713 |
0.463 |
|
| 2022 |
Hamad SH, Montgomery SA, Simon JM, Bowman BM, Spainhower KB, Murphy RM, Knudsen ES, Fenton SE, Randell SH, Holt JR, Hayes DN, Witkiewicz AK, Oliver TG, Major MB, Weissman BE. TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice. Oncogene. PMID 35577980 DOI: 10.1038/s41388-022-02348-0 |
0.356 |
|
| 2022 |
Sutherland KD, Ireland AS, Oliver TG. Killing SCLC: insights into how to target a shapeshifting tumor. Genes & Development. 36: 241-258. PMID 35318269 DOI: 10.1101/gad.349359.122 |
0.377 |
|
| 2021 |
Cargill KR, Stewart CA, Park EM, Ramkumar K, Gay CM, Cardnell RJ, Wang Q, Diao L, Shen L, Fan YH, Chan WK, Lorenzi PL, Oliver TG, Wang J, Byers LA. Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer. Cancer & Metabolism. 9: 33. PMID 34556188 DOI: 10.1186/s40170-021-00270-9 |
0.331 |
|
| 2021 |
Pe'er D, Ogawa S, Elhanani O, Keren L, Oliver TG, Wedge D. Tumor heterogeneity. Cancer Cell. 39: 1015-1017. PMID 34375606 DOI: 10.1016/j.ccell.2021.07.009 |
0.326 |
|
| 2021 |
Ciampricotti M, Karakousi T, Richards AL, Quintanal-Villalonga A, Karatza A, Caeser R, Costa EA, Allaj V, Manoj P, Spainhower KB, Kombak FE, Sanchez-Rivera FJ, Jaspers JE, Zavitsanou AM, Maddalo D, ... ... Oliver TG, et al. Rlf-Mycl gene fusion drives tumorigenesis and metastasis in a mouse model of small cell lung cancer. Cancer Discovery. PMID 34344693 DOI: 10.1158/2159-8290.CD-21-0441 |
0.392 |
|
| 2021 |
Olsen RR, Ireland AS, Kastner DW, Groves SM, Spainhower KB, Pozo K, Kelenis DP, Whitney CP, Guthrie MR, Wait SJ, Soltero D, Witt BL, Quaranta V, Johnson JE, Oliver TG. ASCL1 represses a SOX9 neural crest stem-like state in small cell lung cancer. Genes & Development. PMID 34016693 DOI: 10.1101/gad.348295.121 |
0.49 |
|
| 2020 |
Stewart CA, Gay CM, Xi Y, Sivajothi S, Sivakamasundari V, Fujimoto J, Bolisetty M, Hartsfield PM, Balasubramaniyan V, Chalishazar MD, Moran C, Kalhor N, Stewart J, Tran H, Swisher SG, ... ... Oliver TG, et al. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nature Cancer. 1: 423-436. PMID 33521652 DOI: 10.1038/s43018-019-0020-z |
0.343 |
|
| 2020 |
Huang F, Huffman K, Wang Z, Wang X, Li K, Cai F, Yang C, Cai L, Shih TS, Zacharias LG, Chung AS, Yang Q, Chalishazar MD, Ireland AS, Stewart CA, ... ... Oliver TG, et al. Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small cell lung cancer. The Journal of Clinical Investigation. PMID 33079728 DOI: 10.1172/JCI139929 |
0.363 |
|
| 2020 |
Ireland AS, Micinski AM, Kastner DW, Guo B, Wait SJ, Spainhower KB, Conley CC, Chen OS, Guthrie MR, Soltero D, Qiao Y, Huang X, Tarapcsák S, Devarakonda S, Chalishazar MD, ... ... Oliver TG, et al. MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate. Cancer Cell. PMID 32473656 DOI: 10.1016/J.Ccell.2020.05.001 |
0.495 |
|
| 2020 |
Ireland AS, Oliver TG. Neutrophils Create an ImpeNETrable Shield between Tumor and Cytotoxic Immune Cells. Immunity. 52: 729-731. PMID 32433945 DOI: 10.1016/j.immuni.2020.04.009 |
0.356 |
|
| 2020 |
Melnikova M, Wauer US, Mendus D, Hilger RA, Oliver TG, Mercer K, Gohlke BO, Erdmann K, Niederacher D, Neubauer H, Buderath P, Wimberger P, Kuhlmann JD, Thomale J. Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells. Molecular Oncology. PMID 32037720 DOI: 10.1002/1878-0261.12648 |
0.376 |
|
| 2019 |
Cable J, Finley L, Tu BP, Patti GJ, Oliver TG, Vardhana S, Mana M, Ericksen R, Khare S, DeBerardinis R, Stockwell BR, Edinger A, Haigis M, Kaelin W. Leveraging insights into cancer metabolism-a symposium report. Annals of the New York Academy of Sciences. PMID 31792987 DOI: 10.1111/Nyas.14274 |
0.362 |
|
| 2019 |
Dammert MA, Brägelmann J, Olsen RR, Böhm S, Monhasery N, Whitney CP, Chalishazar MD, Tumbrink HL, Guthrie MR, Klein S, Ireland AS, Ryan J, Schmitt A, Marx A, Ozretić L, ... ... Oliver TG, et al. MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer. Nature Communications. 10: 3485. PMID 31375684 DOI: 10.1038/S41467-019-11371-X |
0.406 |
|
| 2019 |
Guo B, Oliver TG. Partners in Crime: Neutrophil-CTC Collusion in Metastasis. Trends in Immunology. PMID 31101536 DOI: 10.1016/j.it.2019.04.009 |
0.314 |
|
| 2019 |
Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, Heymach JV, Johnson JE, Lehman JM, MacPherson D, Massion PP, Minna JD, Oliver TG, Quaranta V, Sage J, et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nature Reviews. Cancer. PMID 30926931 DOI: 10.1038/S41568-019-0133-9 |
0.326 |
|
| 2018 |
Mollaoglu G, Jones A, Wait SJ, Mukhopadhyay A, Jeong S, Arya R, Camolotto SA, Mosbruger TL, Stubben CJ, Conley CJ, Bhutkar A, Vahrenkamp JM, Berrett KC, Cessna MH, Lane TE, ... ... Oliver TG, et al. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity. 49: 764-779.e9. PMID 30332632 DOI: 10.1016/J.Immuni.2018.09.020 |
0.472 |
|
| 2018 |
Wagner AH, Devarakonda S, Skidmore ZL, Krysiak K, Ramu A, Trani L, Kunisaki J, Masood A, Waqar SN, Spies NC, Morgensztern D, Waligorski J, Ponce J, Fulton RS, Maggi LB, ... ... Oliver TG, et al. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer. Nature Communications. 9: 3787. PMID 30224629 DOI: 10.1038/S41467-018-06162-9 |
0.357 |
|
| 2018 |
Huang F, Ni M, Chalishazar MD, Huffman KE, Kim J, Cai L, Shi X, Cai F, Zacharias LG, Ireland AS, Li K, Gu W, Kaushik AK, Liu X, Gazdar AF, ... Oliver TG, et al. Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers. Cell Metabolism. PMID 30043754 DOI: 10.1016/J.Cmet.2018.06.005 |
0.413 |
|
| 2018 |
Zhang W, Girard L, Zhang YA, Haruki T, Papari-Zareei M, Stastny V, Ghayee HK, Pacak K, Oliver TG, Minna JD, Gazdar AF. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes. Translational Lung Cancer Research. 7: 32-49. PMID 29535911 DOI: 10.21037/Tlcr.2018.02.02 |
0.414 |
|
| 2017 |
Brägelmann J, Böhm S, Guthrie MR, Mollaoglu G, Oliver TG, Sos ML. Family matters: how MYC family oncogenes impact small cell lung cancer. Cell Cycle (Georgetown, Tex.). 0. PMID 28737478 DOI: 10.1080/15384101.2017.1339849 |
0.356 |
|
| 2016 |
Mollaoglu G, Guthrie MR, Böhm S, Brägelmann J, Can I, Ballieu PM, Marx A, George J, Heinen C, Chalishazar MD, Cheng H, Ireland AS, Denning KE, Mukhopadhyay A, Vahrenkamp JM, ... ... Oliver TG, et al. MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition. Cancer Cell. PMID 28089889 DOI: 10.1016/J.Ccell.2016.12.005 |
0.543 |
|
| 2014 |
Masin M, Vazquez J, Rossi S, Groeneveld S, Samson N, Schwalie PC, Deplancke B, Frawley LE, Gouttenoire J, Moradpour D, Oliver TG, Meylan E. GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer. Cancer & Metabolism. 2: 11. PMID 25097756 DOI: 10.1186/2049-3002-2-11 |
0.438 |
|
| 2014 |
Mukhopadhyay A, Berrett KC, Kc U, Clair PM, Pop SM, Carr SR, Witt BL, Oliver TG. Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer. Cell Reports. 8: 40-9. PMID 24953650 DOI: 10.1016/j.celrep.2014.05.036 |
0.379 |
|
| 2013 |
Curry NL, Mino-Kenudson M, Oliver TG, Yilmaz OH, Yilmaz VO, Moon JY, Jacks T, Sabatini DM, Kalaany NY. Pten-null tumors cohabiting the same lung display differential AKT activation and sensitivity to dietary restriction. Cancer Discovery. 3: 908-21. PMID 23719831 DOI: 10.1158/2159-8290.Cd-12-0507 |
0.386 |
|
| 2011 |
Xue W, Meylan E, Oliver TG, Feldser DM, Winslow MM, Bronson R, Jacks T. Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma. Cancer Discovery. 1: 236-47. PMID 21874163 DOI: 10.1158/2159-8290.Cd-11-0073 |
0.321 |
|
| 2010 |
Doles J, Oliver TG, Cameron ER, Hsu G, Jacks T, Walker GC, Hemann MT. Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 107: 20786-91. PMID 21068376 DOI: 10.1073/Pnas.1011409107 |
0.378 |
|
| 2010 |
Oliver TG, Mercer KL, Sayles LC, Burke JR, Mendus D, Lovejoy KS, Cheng MH, Subramanian A, Mu D, Powers S, Crowley D, Bronson RT, Whittaker CA, Bhutkar A, Lippard SJ, et al. Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes & Development. 24: 837-52. PMID 20395368 DOI: 10.1101/Gad.1897010 |
0.441 |
|
| 2009 |
Cowley DO, Rivera-Pérez JA, Schliekelman M, He YJ, Oliver TG, Lu C, O'Quinn R, Salmon ED, Magnuson T, Van Dyke T. Aurora-a kinase is essential for bipolar spindle formation and early development Molecular and Cellular Biology. 29: 1059-1071. PMID 19075002 DOI: 10.1128/Mcb.01062-08 |
0.344 |
|
| 2007 |
Fogarty MP, Emmenegger BA, Grasfeder LL, Oliver TG, Wechsler-Reya RJ. Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 104: 2973-8. PMID 17299056 DOI: 10.1073/Pnas.0605770104 |
0.565 |
|
| 2005 |
Oliver TG, Read TA, Kessler JD, Mehmeti A, Wells JF, Huynh TT, Lin SM, Wechsler-Reya RJ. Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development (Cambridge, England). 132: 2425-39. PMID 15843415 DOI: 10.1242/Dev.01793 |
0.553 |
|
| 2004 |
Oliver TG, Wechsler-Reya RJ. Getting at the root and stem of brain tumors. Neuron. 42: 885-8. PMID 15207233 DOI: 10.1016/J.Neuron.2004.06.011 |
0.533 |
|
| 2003 |
Oliver TG, Grasfeder LL, Carroll AL, Kaiser C, Gillingham CL, Lin SM, Wickramasinghe R, Scott MP, Wechsler-Reya RJ. Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proceedings of the National Academy of Sciences of the United States of America. 100: 7331-6. PMID 12777630 DOI: 10.1073/Pnas.0832317100 |
0.512 |
|
| Show low-probability matches. |